期刊文献+

微信公众号在降低多发性骨髓瘤患者使用硼替佐米皮下注射引起不良反应的应用 被引量:4

The application of WeChat public account in reducing adverse reactions induced by subcutaneous bortezomib injection in patients with multiple myeloma
下载PDF
导出
摘要 目的探讨将微信公众号应用于多发性骨髓瘤患者使用硼替佐米皮下注射引起不良反应的医护工作中的实施效果。方法选取2017年9月~2018年12月解放军总医院第一医学中心血液病科收治的多发性骨髓瘤患者80例,随机数表法分为治疗组和对照组,每组40例,其中治疗组采用微信公众号对血液病科医护人员进行干预,比较两组多发性骨髓瘤患者使用硼替佐米皮下注射后,局部红肿、硬结、疼痛、神经毒性等不良反应的变化。结果治疗组的局部红肿、硬结发生率低于观察组,治疗组的疼痛缓解率高于观察组,差异具有统计学意义(P<0.05),两组神经毒性差异不具备统计学意义(P=0.1203)。结论将微信公众号应用到血液病科医护人员针对多发性骨髓瘤患者使用硼替佐米皮下注射的医护工作中,可降低局部红肿、硬结、疼痛、神经毒性等不良反应的发生率,对多发性骨髓瘤患者得到更好治疗有积极作用。 Objective To explore the effect of WeChat Public account in the treatment of adverse reactions caused by bortezomib subcutaneous injection in multiple myeloma patients.Methods About 80 patients admitted to the hematology department with multiple myeloma treated with bortezomib from September 2017 to December 2018 were divided into treatment group and control group randomly.And intervened using WeChat Public account was used in the treatment group but not in the control group.The changes of local redness,induration,pain,neurotoxicity and other adverse reactions were compared between the two groups after subcutaneous injection of bortezomib.Results The patient's local redlness and induration in treatment group were lower than those in the control group.The rate of pain relief from to treatment group was higher than that in the control group.The differences were statistically significant(P<0.05).The incidence of neurotoxicity of the two groups was not statistically significant in the difference(P=0.1203).Conclusion The application of WeChat public account in reducing adverse reactions induced by subcutaneous bortezomib injection in patients with multiple myeloma can reduce the incidence of local redness,induration,pain,neurotoxicity and other adverse reactions,and play a more effective role in treatment of multiple myeloma patients.
作者 董丽丽 陈平 唐菊英 Dong Lili;Chen Ping;Tang Juying(Department of Hematology,the First Medical Center of Chinese PLA General Hospital,Beijing 100853,China)
出处 《中华保健医学杂志》 2019年第5期452-453,共2页 Chinese Journal of Health Care and Medicine
基金 解放军总医院临床科研扶持基金资助项目(2017FCTSYS-2039)
关键词 多发性骨髓瘤 硼替佐米皮下注射 微信公众号 Multiple myeloma Subcutaneous injection of the bortezomib WeChat public account
  • 相关文献

参考文献9

二级参考文献55

  • 1周秀新,李金娥,李文香,宋梅.留置气泡技术在低分子肝素钙皮下注射中的应用研究[J].护理研究(下旬版),2006,20(1):258-258. 被引量:12
  • 2袁振刚,侯健,周帆,王东星,付卫军,陈玉宝,奚昊,杨盛玲.硼替佐米联合地塞米松治疗16例复发、难治性多发性骨髓瘤患者[J].中华血液学杂志,2006,27(10):653-655. 被引量:21
  • 3Bross PF,KaneR,Farrell AT,et al. Approval summary for borte- zomib for injection in the treatment of multiple myeloma [Jl. Clin Cancer Res,2004,10:3954-3964.
  • 4Moreau P,Pylypenko H. Subcutaneous versus intravenous ad- ministration of bortezomib in patients with relapsed multiple myeloma:a randomized,phase 3,non-inferiority study[J]. Lancet, 2011,12:433-437.
  • 5The International Myeloma Working Group. Criteria for the classification of monoclonal gammopathies,multiple myeloma and related disorders:a report of the International Myeloma Working Group [ J ]. British Journal of Haematology, 2003,121 (5) :749-757.
  • 6Tortti A,Colevas AD,Setser A,et al. Development of a com- prehensive grading system for the adverse effects of cancer treatment[J].Semin Radiat Oncol,2003,13(3) : 176-181.
  • 7Berkowitz A,Walker S. Bortezomib-induced peripheral neuropa- thy in patients with multiple myeloma[J]. Clin J Oncol Nurs, 2012,16( 1 ) :86-89.
  • 8Oakervee HE,Popat R,Curry N,et al. PAD combination thera- py(PS-341/bortezomib,doxorubicin and dexamethesone) for pre- viously untreat patients with multiple myeloma[J]. Br J Haema- tol,2005,129(6) :755-762.
  • 9Moreau P, Pylypenko H, Grosicki S,et al. Subcutaneous versus in- travenous administration of bortezomib in patients with relapsed multiple myeloma: A randomised, phase 3, noninferiority study [J]. Lancet Oneol,2011,12:431 - 440.
  • 10中国医师协会血液科医师分会,中华医学会血液学分会,中国多发性骨髓瘤工作组.中国多发性骨髓瘤诊治指南(2011年修订)[J].中华内科杂志,2011,50;892-896.

共引文献180

同被引文献25

引证文献4

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部